当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2004年第10期
编号:10871773
心脏移植术后的免疫抑制治疗
http://www.100md.com 《第四军医大学学报》 2004年第10期
移植物排斥,,心脏移植;免疫抑制;移植物排斥,0引言,1对象和方法,2结果,3讨论,【参考文献】
     Immunosuppressive therapy following orthotopic heart transplantation

    ZHENG QiJun, CAI ZhenJie, YU ShiQiang, WANG XiaoWu, LIU WeiYong

    Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xian 710033, China

    【Abstract】 AIM: To investigate the therapeutic efficacy and to summarize the experience of immunosuppressive therapy following orthotopic heart transplantation. METHODS: Twentysix cases of othotopic heart transplantation were performed from January 2000 to October 2003. Of them, 17 cases received triple therapy of tacrolimus, mycophenolate mofetil and prednisone postoperation and 9 cases received triple therapy of cyclosporine A, mycophenolate mofetil and prednisone psotoperation. RESULTS: Among the 26 cases, 23 patients survived with good quality of life, 6 patients suffered from 11 episodes of acute rejection, which were reversed after impacting therapy. The main sideeffects were abnormal renal function, hypertension and hyperglycemia. CONCLUSION: Both the triple therapy of tacrolimus, mycophenolate mofetil and prednisone and the triple therapy of cyclosporine A, mycophenolate mofetil and prednisone after orthotopic heart transplantation are of fairly good therapeutic efficacy. But the sideeffects of drugs should be monitored closely. ......

您现在查看是摘要页,全文长 8033 字符